This page lists the scientific publications related to the EVAg project. The default filter is set to "publications for which the research was funded by the EVAg project". You can change this filter to another value by picking a different filter from the drop-down list and clicking on the "Apply" button.

326 publications displayed

Datesort ascending Name Journal EVAg
Dec 2021 Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection Nature Communications Research funded by EVAg, Published by EVAg end-user
Dec 2021 Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards Malaria Journal Research funded by EVAg, Published by EVAg end-user
Dec 2021 Determination of the characteristic inactivation fluence for SARS-CoV-2 under UV-C radiation considering light absorption in culture media Scientific Reports Research funded by EVAg, Published by EVAg end-user
Dec 2021 Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model Nature Communications Research funded by EVAg, Published by EVAg partner
Dec 2021 A novel and sensitive real-time PCR system for universal detection of poxviruses Scientific Reports Research funded by EVAg, Published by EVAg partner
Dec 2021 Complementary methods for SARS-CoV-2 diagnosis in times of material shortage Scientific Reports Research funded by EVAg, Published by EVAg end-user
Dec 2021 Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions Scientific Reports Research funded by EVAg, Published by EVAg end-user
Nov 2021 Evaluation of formulations to improve SARS-CoV-2 viability and thermostability after lyophilisation Journal of Virological Methods Research funded by EVAg, Published by EVAg partner
Sep 2021 Inactivation of SARS-CoV-2 by Simulated Sunlight on Contaminated Surfaces Microbiology Spectrum Research funded by EVAg, Published by EVAg end-user
Sep 2021 Transmission of SARS-CoV-2 from Human to Domestic Ferret Emerging Infectious Diseases Research funded by EVAg, Published by EVAg partner
Sep 2021 Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2 Antiviral Research Research funded by EVAg, Published by EVAg partner
Aug 2021 Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan PLoS ONE Research funded by EVAg, Published by EVAg end-user
Aug 2021 A SARS-CoV-2 mutant from B.1.258 lineage with ∆H69/∆V70 deletion in the Spike protein circulating in Central Europe in the fall 2020 Virus Genes Research funded by EVAg, Published by EVAg partner
Aug 2021 The Post-Acute Phase of SARS-CoV-2 Infection in Two Macaque Species Is Associated with Signs of Ongoing Virus Replication and Pathology in Pulmonary and Extrapulmonary Tissues Viruses Research funded by EVAg, Published by EVAg end-user
Aug 2021 Amaryllidaceae Alkaloid Cherylline Inhibits the Replication of Dengue and Zika Viruses Antimicrobial Agents and Chemotherapy Research funded by EVAg, Published by EVAg end-user
Aug 2021 The New Generation hDHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses Microorganisms Research funded by EVAg, Published by EVAg end-user
Aug 2021 Real-Life Head-to-Head Comparison of Performance of Two High-Throughput Automated Assays for the Detection of SARS-CoV-2 RNA in Nasopharyngeal Swabs The Journal of Molecular Diagnostics Research funded by EVAg, Published by EVAg partner
Aug 2021 Decay of infectious SARS-CoV-2 and surrogates in aquatic environments Water Research Research funded by EVAg, Published by EVAg end-user
Jul 2021 Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 Annals of Internal Medicine Research funded by EVAg, Published by EVAg end-user
Jul 2021 Multi‐species ELISA for the detection of antibodies against SARS‐CoV‐2 in animals Transboundary and Emerging Diseases Research funded by EVAg, Published by EVAg partner
Jul 2021 Complete Genome Sequence of African Swine Fever Virus Isolated from a Domestic Pig in Timor-Leste, 2019 Microbiology Resource Announcements Research funded by EVAg, Published by EVAg partner
Jul 2021 Seroprevalence of severe acute respiratory syndrome coronavirus 2 in Slovenia: results of two rounds of a nationwide population study on a probability-based sample, challenges and lessons learned Clinical Microbiology and Infection Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Jul 2021 Effective screening strategy against SARS-CoV-2 on self-collected saliva samples in primary school setting: A pilot project Journal of Infection Research funded by EVAg, Published by EVAg end-user
Jun 2021 COVID-19 laboratory preparedness and response in the Americas Region: Lessons learned PLoS ONE Research funded by EVAg, Published by EVAg end-user
Jun 2021 Nonsterile immunity to cryptosporidiosis in infants is associated with mucosal IgA against the sporozoite and protection from malnutrition PLoS Pathogens Research funded by EVAg, Published by EVAg end-user
Jun 2021 SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19 PLoS ONE Research funded by EVAg, Published by EVAg end-user
Jun 2021 Endonuclease-based genotyping of the RBM, a first-line method for the surveillance of emergence or evolution of SARS-CoV-2 Variants Research funded by EVAg, Published by EVAg partner
Jun 2021 Rapid screening for SARS-CoV-2 variants of concern in clinical and environmental samples using nested RT-PCR assays targeting key mutations of the spike protein Water Research Research funded by EVAg, Published by EVAg end-user
Jun 2021 Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection Antiviral Research Research funded by EVAg, Published by EVAg partner
Jun 2021 Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutralization assay Journal of Clinical Virology Research funded by EVAg, Related to EVAg product, Published by EVAg partner
Jun 2021 Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA European Journal of Clinical Microbiology & Infectious Diseases Research funded by EVAg, Published by EVAg end-user
Jun 2021 Detection and complete genome sequence of a divergent isolate of cucumber fruit mottle mosaic virus on Coccinia grandis in Sudan Archives of Virology Research funded by EVAg, Published by EVAg end-user
May 2021 Validation of Inactivation Methods for Arenaviruses Viruses Research funded by EVAg, Published by EVAg partner
May 2021 Whole-genome sequencing and phylogenetic analysis of rabies viruses from Jordan PLoS Neglected Tropical Diseases Research funded by EVAg, Published by EVAg partner
May 2021 The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates Science Translational Medicine Research funded by EVAg, Published by EVAg end-user
May 2021 Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures American Journal of Physiology-Lung Cellular and Molecular Physiology Research funded by EVAg, Published by EVAg end-user
May 2021 Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies Cell Reports Medicine Research funded by EVAg, Published by EVAg partner
Apr 2021 Biological Cloth Face Coverings—The Reduction of SARS-CoV-2 and Influenza (H1N1) Infectivity by Viruferrin™ Treatment Materials Research funded by EVAg, Published by EVAg end-user
Apr 2021 Macrolides May Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Entry into Cells: A Quantitative Structure Activity Relationship Study and Experimental Validation Journal of Chemical Information and Modeling Research funded by EVAg, Published by EVAg end-user
Apr 2021 Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies Viruses Research funded by EVAg, Published by EVAg partner
Apr 2021 SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus Viruses Research funded by EVAg, Published by EVAg partner
Apr 2021 Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods Pharmaceuticals Research funded by EVAg, Published by EVAg end-user
Apr 2021 The stability of an isolate of the SARS-CoV-2 B.1.1.7 lineage in aerosols is similar to three earlier isolates The Journal of Infectious Diseases Research funded by EVAg, Published by EVAg end-user
Apr 2021 Saliva Is a Valid Alternative to Nasopharyngeal Swab in Chemiluminescence-Based Assay for Detection of SARS-CoV-2 Antigen Journal of Clinical Medicine Research funded by EVAg, Published by EVAg partner
Apr 2021 In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy Journal of Infection Research funded by EVAg, Published by EVAg partner
Apr 2021 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Cell Research funded by EVAg, Published by EVAg end-user
Mar 2021 COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August–October 2020 Biomolecules Research funded by EVAg, Published by EVAg partner
Mar 2021 An Integrated Molecular Approach to Untangling Host–Vector–Pathogen Interactions in Mosquitoes (Diptera: Culicidae) From Sylvan Communities in Mexico Frontiers in Veterinary Science Research funded by EVAg, Published by EVAg partner
Mar 2021 COVID-19 Vaccine Candidates Based on Modified Vaccinia Virus Ankara Expressing the SARS-CoV-2 Spike Protein Induce Robust T- and B-Cell Immune Responses and Full Efficacy in Mice Journal of Virology Research funded by EVAg, Published by EVAg end-user
Mar 2021 Accuracy of serological testing for SARS‐CoV‐2 antibodies: First results of a large mixed‐method evaluation study Allergy Research funded by EVAg, Published by EVAg end-user

Pages